4h

U.S. stock futures pointed higher this morning as a major pharmaceutical acquisition dominated premarket trading and pushed several biotech and technology names sharply higher. At 8:34 a.m. ET, S&P 500 futures had added 0.1%, Nasdaq 100 futures climbed 0.4% and Dow Jones futures advanced 0.3%. The story of the session belonged to AbbVie, which announced […] The post Apogee Therapeutics and AbbVie shake up immunology appeared first on Rolling Out .